Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Cash Conversion Cycle 2011-2024 | EGRX

Annual Cash Conversion Cycle Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
139 140 112 96.1 104 39.2 2.23 406 53.3 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
406 2.23 121

Quarterly Cash Conversion Cycle Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
308 276 - 320 237 96.3 - 60.3 43.2 85.2 - 112 126 126 90.8 115 82.8 102 108 101 91.8 64.2 105 -52.1 27.7 57 47.5 -3.07 -1.16 103 132 690 704 116 79.2 293 55.9 78.3 22.2 27.3 27.5 - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
704 -52.1 133